The Asheville Project: Long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma

Journal of the American Pharmacists Association

Volumn 46, Issue 2, 2006, Pages 133-147

  Bunting, Barry A ^a,c   Cranor, Carole W ^b  

^a Mission Hospital   (United States)

^b North Carolina Association of Pharmacists   (United States)

^c Mission Hospitals   (United States)

Author keywords

Asheville Project; Asthma; Health care costs; Health outcomes; Medication therapy management

Indexed keywords

ARTICLE; ASTHMA; COMMUNITY CARE; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE SEVERITY; ECONOMIC ASPECT; EMERGENCY WARD; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; HOSPITAL ORGANIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHARMACIST; PHARMACY; SYMPTOM; TREATMENT PLANNING; ABSENTEEISM; ADULT; ECONOMICS; FEMALE; HEALTH CARE COST; HUMANISM; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; UNITED STATES;

ABSENTEEISM; ADULT; ASTHMA; COMMUNITY PHARMACY SERVICES; FEMALE; HEALTH CARE COSTS; HUMANISM; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 33645814371     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434506776180658     Document Type: Article

References (41)

1. American Lung Association Epidemiology and Statistics Unit Research and Scientific Affairs. Trends in asthma morbidity and mortality. American Lung Association; April 2004. Accessed at www.lungusa.org, April 1, 2005.
2. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the diagnosis and management of asthma. Bethesda, Md.: National Institutes of Health, National Heart, Lung, and Blood Institute, 1991. NIH Publication 91-3042.
3. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Bethesda, Md.: National Institutes of Health, National Heart, Lung, and Blood Institute, 1997. NIH Publication 97-4051. Accessed at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln. pdf, April 1, 2005.
4. National Asthma Education and Prevention Program. Quick Reference NAEPP Expert Panel Report: Guidelines for the diagnosis and management of asthma. Update on selected topics 2002. Bethesda, Md.: National Institutes of Health, National Heart, Lung, and Blood Institute, July, 2002. NIH Publication No. 02-5075. Accessed at: www.nhlbi.nih.gov/guidelines/asthma/asthmafullrpt.pdf, January 31, 2006.
5. Legorreta AP, Christian-Herman J, O'Connor RD, et al. Compliance with national asthma management guidelines and specialty care. Arch Intern Med. 1998;158:457-64.
6. Donnelly JE, Donnelly WJ, Thong YH. Inadequate parental understanding of asthma medications. Ann Allergy. 1989;62:337-41.
7. Birkhead GB, Attaway NJ, Strunk RC, et al. investigation of a cluster of deaths of adolescents from asthma: evidence implicating inadequate treatment and poor patient adherence with medications. J Allergy Clin Immunol. 1989;84:484-91.
8. Brooks CM, Richards JM, Hohler CL, et al. Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales. Med Care. 1994;32:298-307.
9. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 pt 2):S60-S78.
10. Warner JO. Review of prescribed treatment for children with asthma in 1990. BMJ. 1995;311:663-6.
11. Bender B, Milgrom H. Compliance with asthma therapy: a case for shared responsibility. Asthma. 1996;33:199-202.
12. Bailey WC, Richards JM, Brooks CM, et al. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990;150:1664-8.
13. Belda A. Misuse of asthma-medication inhalers. CMAJ. 1995;153:1069.
14. Mahr T, Rooney B, Pearse C. After the NHBLI guidelines: management changes in asthmatic children. J Allergy Clin Immunol. 1994;93:184.
15. Magione S, Skobeloff E, Fell SB. Awareness and implementation of the 1991 asthma guidelines: a medical survey. Chest. 1994;106:154s.
16. Cramer JA, Collins JF, Mattsen RH. Can categorization of patient background problems be used to determine early termination in a clinical trial? Controlled Clin Trials. 1988;9:47-63.
17. Kellowy JS, Wyatt RA, Adlis SA. Comparison of patients compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-52.
18. Taylor DM, Auble TE, Calhoun WJ, et al. Current outpatient management of asthma shows poor compliance with international guidelines Chest. 1999;116:1638-45.
19. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study. Can Respir J. 2003;10(4):195-202.
20. Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacist: a pharmaceutical care demonstration project. J Clin Pharm Ther. 2003;28:395-402.
21. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? Thorax. 2003;58:851-4.
22. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21:1196-203.
23. Chan DS, Callahan CW, Moreno C. Multidisciplinary education and management program for children with asthma. Am J Health Syst Pharm. 2001;58:1413-7.
24. Yanchick JK. Implementation of a drug therapy monitoring clinic in a primary-care setting. Am J Health Syst Pharm. 2000;57(suppl 4):S30-S34.
25. Narhi U, Airaksinen M, Tanskansen P, et al. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. Clin Pharm Ther. 2000;25:177-83.
26. Fischer LR, Scott LM, Boonstra DM, et al. Pharmaceutical care for patients with chronic conditions. J Am Pharm Assoc. 2000;40:174-80.
27. Sondergaard B, Thorleifsson S, Herbord H, et al. Quality assurance of drug therapy for patients with asthma. Ugeskr Laeger. 2000;162:480-6.
28. Knoell DL, Pierson JF, March CB, et al. Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic. Pharmacotherapy. 1998;18:1365-74.
29. Soondergaard B, Davidsen F, Kirkeby B, et al. The economics of an intensive education programme for asthmatic patients: a prospective controlled trial. Pharmacoeconomics. 1992;1:207-12.
30. Pauley TR, Magee MJ, Cury JD. Pharmacist-managed physician-directed asthma management program reduces emergency department visits. Ann Pharmacother. 1995;29:5-9.
31. Munroe WP, Junz K, Dalmadey-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997;19:113-23.
32. Gonzalez-Martin G, Joo I, Sanchez I. Evaluation of the impact of a pharmaceutical care program in children with asthma. Patient Educ Couns. 2003;49:13-8.
33. Coleman CI, Reddy P, Laster-Bradley NM, et al. Effect of practitioner education on adherence to asthma treatment guidelines. Ann Pharmacother. 2003;37:956-61.
34. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airway disease: a randomized controlled trial. JAMA, 2002;288:1594-602.
35. Stergachis A, Gardner JS, Anderson MT, et al. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc. 2002;42:743-52.
36. Kradjan WA, Schultz R, Christensen DB, Stergachis A, et al. Patients' perceived benefit from and satisfaction with asthma-related pharmacy services. J Am Pharm Assoc. 1999;39:658-66.
37. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:183-4.
38. Garrett, DG, Bluml, BM. Patient Self-Management Program for Diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005;45:130-7.
39. Cisternas MG, Blanc RD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111:1212-8.
40. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research. Chicago: Rand McNally; 1963.
41. Cook TD, Campbell DT. Quasi-experimentation. Design and analysis issues for field studies. Chicago: Rand McNally; 1979.